Shanghai, China

Chunyang Cao

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chunyang Cao. Retrieved from https://idiyas.com/inventor/chunyang-cao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Chunyang Cao

Introduction

Chunyang Cao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the treatment of epilepsy. His innovative work has led to the development of a unique antiepileptic toxin known as Martentoxin.

Latest Patents

Chunyang Cao holds a patent for the antiepileptic toxin Martentoxin and its uses. This patent describes Martentoxin, its derivatives, and their application in preparing compositions for treating and preventing epilepsy. It has been confirmed for the first time that Martentoxin can effectively treat and prevent epileptic symptoms, marking a significant advancement in epilepsy treatment.

Career Highlights

Cao is affiliated with the Chinese Academy of Sciences, where he conducts his research and development work. His dedication to advancing medical science has positioned him as a key figure in the field of neurology.

Collaborations

Chunyang Cao has collaborated with notable colleagues, including Xinlian Liu and Jie Tao, to further enhance the research and application of his inventions.

Conclusion

Chunyang Cao's innovative contributions to the field of epilepsy treatment through his patent on Martentoxin highlight his role as a leading inventor in medical science. His work continues to pave the way for new therapeutic options for patients suffering from epilepsy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…